Inspire Medical Systems, Inc. vs Merck & Company, Inc. — Stock Comparison
Q·Score Breakdown
8
Bullish
Overall
6.7
Neutral
Quality
Health
Growth
Valuation
Sentiment
INSP
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ cautious analyst consensus — few Buy ratings.
MRK
Forward P/E of 11.5× is low relative to sector peers.
Analyst Consensus
HOLD
Target $72.25 (+27.4%)
12 analysts
BUY
Target $129.74 (+15.7%)
27 analysts
Fundamentals
INSP
MRK
11.6×
Trailing P/E
31.5×
21.9×
Forward P/E
11.5×
15.9%
Profit Margin
13.6%
85.4%
Gross Margin
76.6%
19.8%
ROE
—
12.2%
Revenue Growth
4.9%
308.4%
Earnings Growth
—
0.86
Beta
0.28
—
Price / Book
—
$1.6B
Market Cap
$277.0B
$48 – $163
52-Week Range
$73 – $125
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →